Citations 1
Young serum protects against memory impairment in APP/PS1 transgenic mice by blocking neutrophil infiltration
Guo, Kaihua , Qi, Fangfang , Zuo, Zejie , Wu, Tong , Liu, Hao , Tang, Jiaoling , Wang, Qingbo , Xie, Yufeng , Tan, Liren, Yang, Yunjie , Zhang, Xiaoran , Xu, Jie , Yao, Zhibin , Wang, Shengwen , Qi, Fangfang , Hu, Kaishun , Wang, Rui Ting , Wu, Long‐Jun
No container title available | August 9, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available
Abstract Activation of innate immunity in the brain is a prominent feature of Alzheimer's disease (AD). The present study investigated the regulation of innate immunity by young serum in a transgenic AD mouse model. We found that young serum significantly reduced the number of neutrophils and microglial reactivity in the brains of APP/PS1 mice. Neutrophil depletion via Ly6G neutralizing antibodies mimicked the benefits of young serum on AD brain functions. Serum proteomic analysis of young serum revealed significant enrichment of the factors VEGF-A and CXCL1, which are crucial for neutrophil migration and chemotaxis, leukocyte migration, and cell chemotaxis. Intravenously injected VEGF-A reversed Aβ-induced decreases in Cdk5 and increases in CXCL1 in vitro and blocked neutrophil infiltration into the AD brain. Endothelial Cdk5 overexpression conferred an inhibitory effect on CXCL1 and neutrophil infiltration and thereby restored memory in APP/PS1 mice. Our data uncover a previously unknown link between blood-derived VEGF signaling and neutrophil infiltration and provide a rationale for targeting endothelial Cdk5 signaling as a potential therapeutic strategy for AD.